openPR Logo
Press release

Artificial Pancreas Device System (APDS) Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

09-04-2018 12:17 PM CET | Health & Medicine

Press release from: CMI - Biotechnology Industry

Artificial Pancreas Device System (APDS) Market

Artificial Pancreas Device System (APDS) Market

Administering insulin on daily basis is cumbersome for type 1 diabetes (T1D) patients in a busy lifestyle. While devices such as insulin pumps, pens, and jet injectors have made living with diabetes less stressful by ridding users of relatively painful insulin delivering devices such as needles and syringes. Juvenile Diabetes Research Foundation (JDRF) is working in collaboration with many industry players such as Medtronic, Inc., Johnson & Johnson, and Tandem Diabetes Care, Inc. to develop innovative insulin and glucose monitoring systems/devices.

Artificial pancreas is the outcome of these collaborations which is also encouraged for use by the FDA. Artificial pancreas device system (APDS) consists of an insulin pump, sensor, transmitter, and a receiver. MiniMed 530G from Medtronic, Inc. was the first artificial pancreas device system (APDS) approved by FDA.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/79

Eating habits of type 1 diabetes patients is highly curtailed, complemented by regular administration of insulin. Type 1 diabetes patients require multiple doses of insulin in a day and all-round the year. Advancements in research and technology has led to commercialization of easy-to-us insulin delivery systems such as insulin pens, pumps, inhaled insulin, and injectors. Use of syringes to deliver insulin has become obsolete with the introduction of advanced and easy-to-use insulin delivery systems mentioned above. Moreover, these systems offer the convenience to self-administer insulin at home. An artificial pancreas is a novel concept that promises to revolutionize the entire diabetes market. The system automatically detects glucose level in patient’s blood or plasma and accordingly administers the necessary dosage of insulin. Medtronic’s MiniMed 670G is one such wearable artificial pancreas. The system is automated to monitor glucose levels and deliver insulin through an insulin pump attached to the system. The artificial pancreas system comprises a transmitter, sensor, and insulin pump. This helps in continuous monitoring and diabetes management at ease.

Download PDF Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/79

Key Vendors of Artificial Pancreas Device System (APDS) Market: Medtronic, Medtrum, Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Bigfoot Biomedical, and Insulet Corporation

Detailed Segmentation:

Global Artificial Pancreas Device System (APDS) Market, By Technology:
Threshold Suspended Device Systems
Treat to Range/Control to Range (TTR/CTR)
Treat to Target/ Control to Target (TTR/CTT)

Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel:

E-commerce
Standalone Retail Shops
Hospitals

Global Artificial Pancreas Device System (APDS) Market, By End User:

Type 1 Diabetic Patients
Type 2 Diabetic Patients

Global Artificial Pancreas Device System (APDS) Market, By Geography:

North America
Europe
Asia-Pacific
Latin America
Middle East
Africa

Company Profiles

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Pancreas Device System (APDS) Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 here

News-ID: 1218711 • Views: 509

More Releases from CMI - Biotechnology Industry

Global Human Microbiome Market - Merck & Co. Inc., Affymetrix Inc., Vithera Phar …
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Next Generation Sequencing Market - Global Industry Insights, Trends, Outlook, a …
Next Generation Sequencing (NGS) is a powerful, flexible, and indispensable biological tool that is used in several areas of biological study. NGS technologies help in generating genome-wide sequence data in a couple of days. These technologies are highly parallelized allowing to sequence thousands to millions of molecules at the same time. The main advantage of these platforms is determination of the sequenced data from amplified single DNA fragments, avoiding the
Digital Genome Market - Global Industry Insights, Trends, Outlook, and Opportuni …
Digital genome is the complete digital set of genes or genetic material present in a cell or organism. Genome is the branch of biology that deals with the study of genes and their functions. Digital genome allows the conversion of this large volume of data into products and services. A digital genome act as a pivot table that allows instant access to trait combinations to solve seemingly endless custom queries.
Plant Stem Cell Market - Global Industry Insights, Trends, Outlook, and Opportun …
Plant stem cells are undifferentiated cells within the meristems of plants. Plant stem cells serve as the origin of plant vitality as they maintain themselves and provide a steady supply of precursor cells to form various tissues and organs in plants. Plant stem cells are characterized by two distinctive properties namely its ability to create differentiated cell types and to self-renew such that the number of stem cells remain stable.

All 5 Releases


More Releases for Artificial

Artificial Paintings Releases NFT
Artificial Paintings - a tech company that trained AI to create works of digital art - has transformed its AI-driven digital paintings into NFTs. The company has already presented more than a hundred of NFTs and plans to keep releasing more. An NFT (non-fungible token) is a unique piece of digital artwork stored on a digital ledger. Non-fungible means that the digital asset is not interchangeable. In 2021, the NFT
Artificial Blood Market Development
Artificial Blood Market Potential According to the World Health Organization (WHO), there are around 50,000 stem cell transplantations performed annually worldwide, which include 2,000 cord blood hematopoietic stem cell transplants performed each year. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. According to the New
Artificial intelligence for industrial microbiology
Munich, Germany, November 23, 2017 - vermicon AG, the specialist for microbiological solutions, is launching the new Scan VIT® system for analysis of microorganisms. It is able to quantify and specifically identify single cells directly and without time-consuming enrichment steps. A fully automated analysis evaluation is provided by the intelligent VIT® Vision software, which is the centerpiece of the new, patented technology. In contrast to conventional rapid test methods, the
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells.  For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard and
Global Artificial Intelligence Market
According to a new report, Global Artificial Intelligence Market (2016-2022), published by KBV Research, the global artificial intelligence market is estimated to reach USD 16,274.0 Million by 2022, at a CAGR of 44.5% from 2016 to 2022. The North America market dominated the Global Artificial Intelligence Market in 2015, and would continue to be a dominant market till 2022; thereby growing at a CAGR of 42.7% during the forecast period.